SCYX Scynexis Inc

SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  05/02/2014
Outstanding shares:  23,950,121
Average volume:  567,283
Market cap:   $177,949,399
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    811292200
ISIN:        US8112922005
Valuation   (See tab for details)
PE ratio:   -33.56
PB ratio:   4.70
PS ratio:   14.16
Return on equity:   -123.18%
Net income %:   -368.73%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy